Sumi Hidaka
Overview
Explore the profile of Sumi Hidaka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
405
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitomo A, Tanabe K, Muraoka S, Yanai M, Hidaka S, Kobayashi S
Transpl Immunol
. 2025 Mar;
90:102213.
PMID: 40024311
We report two cases of ABO-incompatible living-donor kidney transplantation (ABOi KT) performed in patients with exceptionally high ABO antibody titers. Both donor and recipient refused blood transfusions for religious reasons,...
2.
Kobayashi S, Ohtake T, Mochida Y, Ishioka K, Oka M, Maesato K, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004582
Vascular calcification (VC) is a characteristic feature of atherosclerosis in patients with chronic kidney disease (CKD), and coronary artery calcification (CAC) significantly impacts future cardiovascular events and mortality. Although factors...
3.
Kobayashi S, Hidaka S, Tanabe K
Clin Kidney J
. 2025 Jan;
18(1):sfae392.
PMID: 39877207
Background: Chronic kidney disease (CKD) is a significant risk factor for cerebrovascular disease. However, there is limited research on how successful living donor kidney transplantation (LDKT) affects cerebral blood flow...
4.
Ohtake T, Sato T, Tsukiyama T, Muraoka S, Mitomo A, Maruyama H, et al.
World J Stem Cells
. 2024 Dec;
16(12):1012-1021.
PMID: 39734483
Background: To date, no specific treatment has been established to reverse progressive chronic kidney disease (CKD). Aim: To evaluate the safety and efficacy of autologous CD34 cell transplantation in CKD...
5.
Mitomo A, Ishioka K, Yanai M, Ohtake T, Hidaka S, Kobayashi S
BMC Nephrol
. 2024 Dec;
25(1):451.
PMID: 39695431
Background: Recently, the incidence of caffeine intoxication has been on an upward trend, with severe outcomes. However, acute kidney injury (AKI) resulting from renal pathologies secondary to caffeine intoxication is...
6.
Obata S, Hidaka S, Kobayashi S
Transpl Infect Dis
. 2024 Dec;
27(1):e14419.
PMID: 39692587
No abstract available.
7.
Hidaka S, Kobayashi S, Tanabe K
Kidney360
. 2024 Dec;
PMID: 39666313
Background: The impact of kidney transplantation (KT) on left ventricular (LV) remodeling remains poorly understood. This study aimed to evaluate the effect of KT on LV reverse remodeling, utilizing echocardiographic...
8.
Salybekov A, Okamura S, Ohtake T, Hidaka S, Asahara T, Kobayashi S
Cells
. 2024 Aug;
13(16.
PMID: 39195224
Under vasculogenic conditioning, certain pro-inflammatory subsets within peripheral blood mononuclear cells (PBMCs) undergo phenotypic transformation into pro-regenerative types, such as vasculogenic endothelial progenitor cells, M2 macrophages, and regulatory T cells....
9.
Nakatani S, Kawano H, Sato M, Hoshino J, Nishio S, Miura K, et al.
Clin Exp Nephrol
. 2024 May;
28(10):1004-1015.
PMID: 38734869
Background: Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD) are major genetic polycystic kidney diseases that can progress to end-stage kidney disease (ESKD). Longitudinal data...
10.
Salybekov A, Wolfien M, Hahn W, Hidaka S, Kobayashi S
Biomedicines
. 2024 Mar;
12(3).
PMID: 38540219
The use of artificial intelligence (AI) in healthcare is transforming a number of medical fields, including nephrology. The integration of various AI techniques in nephrology facilitates the prediction of the...